Jenny Greig has a BSc (Hons) in Pharmacology, and a Ph.D. in Gene Therapeutics from the University of Glasgow, Scotland. Jenny joined GTP in 2010 as a post-doctoral researcher investigating muscle and liver transduction with gene therapy vectors. In her current role at GTP, she leads a team of scientists developing pre-clinical approaches for the treatment of liver disease from proof-of-concept through to Investigational New Drug enabling studies to support submission of applications to regulatory agencies.
Jenny is a member of the American Society for Gene and Cell Therapy and is part of the ASGCT New Investigator Committee. She is the author of 13 peer-reviewed scientific papers and is co-inventor on five patent applications.
Learn more about our staff and scientists.